Position in ZTS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$650,117
+$469,611 QoQ
Shares Held
9,047
+492.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#740
of 1,412 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $14,581,452 across 56 Drug Manufacturers - Specialty & Generic names. ZTS ranks #6 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
24,261 | $4,088,948 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,216 | $3,368,015 | |
| 3 | VTRS |
Viatris Inc
|
83,877 | $1,331,966 | |
| 4 | HLN |
Haleon plc
|
81,966 | $764,742 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
21,768 | $737,499 | |
| 6 | ZTS |
Zoetis Inc.
This page
|
9,047 | $650,117 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
39,210 | $628,536 | |
| 8 | IRWD |
Ironwood Pharmaceuticals Inc
|
126,966 | $534,526 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $650,117 | 9,047 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $180,506 | 1,527 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $638,284 | 5,073 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,668,046 | 31,903 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $815,306 | 5,228 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,448,919 | 8,800 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,778,055 | 10,913 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,426,664 | 7,302 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,257,900 | 7,256 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $890,382 | 5,262 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,011,323 | 5,124 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $865,724 | 4,976 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $371,628 | 2,158 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $355,848 | 2,138 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $282,841 | 1,930 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $262,176 | 1,768 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $297,541 | 1,731 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $320,225 | 1,698 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $411,678 | 1,687 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $341,492 | 1,759 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $332,652 | 1,785 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $287,473 | 1,737 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $290,885 | 1,759 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $249,823 | 1,823 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $251,738 | 2,139 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||